PH, LC and the management have a lot of skin in the game and will surely want to maximise their personal investments, while the rest of us small fish should be dragged along smiling.
At this stage we can only guess at what will transpire - Will it be a sell out or a partnership? Will it be Her-Vaxx or the whole B-Cell platform? Whatever it is I'm sure the price it will be appropriate for the package.
CF 33 is yet to enter Phase 1 testing, and it is inconceivable to me that this would be "given away" for a song.
This is just my view, so have a bit bit more patience and hopefully a really Happy Christmas. After all, Scrooge is nowhere to be seen!
GLTAH, DYOR
Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-119
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $413.7K | 8.448M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 112 | 14818485 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 13411 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |